Beranda › Sarkoma Jaringan Lunak › Texas › Dallas
Uji klinis Sarkoma Jaringan Lunak di Dallas, TX
6 studi untuk Sarkoma Jaringan Lunak mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
- Research Site, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Menerima pesertaFase 1/2
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
Menerima pesertaFase 1
- Ut Southwestern Medical Center, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Menerima pesertaFase 1/2
- UT Southwestern Medical Center, Dallas
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Menerima pesertaFase 1/2
- Children's Health Dallas, Dallas
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Mary Crowley Cancer Research, Dallas
Uji klinis Sarkoma Jaringan Lunak di kota lain
- Houston, TX32 studi
- New York City, NY19 studi
- Boston, MA18 studi
- St. Louis, MO14 studi
- Los Angeles, CA13 studi
- Columbus, OH13 studi
- Washington, DC12 studi
- Memphis, TN11 studi
- Philadelphia, PA10 studi
- Rochester, MN9 studi
- Nashville, TN9 studi
- Aurora, CO9 studi
Studi lain di Dallas
- Kanker Payudara55 studi
- Kanker Paru Non-Sel Kecil52 studi
- Kanker Metastatik42 studi
- Gagal Jantung42 studi
- Kanker (semua jenis)37 studi
- Kanker Prostat36 studi
- Kanker Kolorektal33 studi
- Obesitas30 studi
- Kanker Ovarium28 studi
- Kanker Kandung Kemih27 studi
- Kanker Paru27 studi
- Kanker Endometrium24 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.